NPY and glaucoma: NPY exerts neuroprotective actions in various brain regions, and also in the retina (Alvaro et al., 2008b; Santos-Carvalho et al., 2013a), suggesting that NPY receptors might be possible therapeutic targets for retinal degenerative diseases such as glaucoma.